Transvaginal ovarian drilling for polycystic ovary syndrome prior to in vitro fertilization dramatically improves embryo yield, implantation, and ongoing pregnancy rates
- PMID: 39718714
- PMCID: PMC11950547
- DOI: 10.1007/s10815-024-03362-9
Transvaginal ovarian drilling for polycystic ovary syndrome prior to in vitro fertilization dramatically improves embryo yield, implantation, and ongoing pregnancy rates
Abstract
Purpose: To evaluate the effect of transvaginal ovarian drilling (TVOD) on IVF outcomes in subjects with clomiphene-resistant PCOS and a history of IVF failure.
Methods: Between 2008 and 2011, 19 subjects with sonographically PCOS and a history of failure to ovulate to high-dose clomiphene citrate were prospectively followed and underwent TVOD at a university hospital-based IVF program.
Results: In 15 subjects who underwent 30 fresh paired IVF cycles TVOD resulted in a significantly higher number of oocytes retrieved (7.2 ± 5.9 vs. 13.2 ± 5.9, p = 0.007), mature oocytes retrieved (4.6 ± 3.4 vs. 9.5 ± 5.2, p = 0.002), embryos (3.8 ± 2.7 vs. 8.5 ± 4.5, p = 0.0002), and blastocysts (0.73 ± 1.33 vs. 2.77 ± 2.7, p = 0.037). Among all IVF cycles, 19 subjects underwent 23 fresh IVF cycles prior to TVOD and 21 fresh cycles within 6 months following TVOD lead to higher implantation (0.10 vs. 0.37, p = 0.001), clinical pregnancy (17.4% vs. 61.9%, p = 0.002), and ongoing pregnancy rates (4.4% vs. 47.6%, p = 0.014).
Conclusion: In this prospective cohort study, TVOD appears to markedly improve IVF outcomes in subjects with clomiphene resistant PCOS and a history of IVF failure.
Keywords: IVF; Infertility; PCOS; Transvaginal ovarian drilling.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.Cochrane Database Syst Rev. 2012 Jun 13;(6):CD001122. doi: 10.1002/14651858.CD001122.pub4. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Feb 11;2:CD001122. doi: 10.1002/14651858.CD001122.pub5. PMID: 22696324 Updated.
-
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Sep 27;9:CD010287. doi: 10.1002/14651858.CD010287.pub4. PMID: 29797697 Free PMC article. Updated.
-
Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.Cochrane Database Syst Rev. 2001;(4):CD001122. doi: 10.1002/14651858.CD001122. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001122. doi: 10.1002/14651858.CD001122.pub2. PMID: 11687100 Updated.
-
Randomized controlled trial to evaluate the impact of follicle priming on IVM outcomes in women with polycystic ovaries: CFA versus FSH-B.Hum Reprod. 2025 Jun 1;40(6):1127-1137. doi: 10.1093/humrep/deaf053. Hum Reprod. 2025. PMID: 40194780 Clinical Trial.
-
Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.Cochrane Database Syst Rev. 2000;(2):CD001122. doi: 10.1002/14651858.CD001122. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001122. doi: 10.1002/14651858.CD001122. PMID: 10796746 Updated.
Cited by
-
Predictive value of serum sortilin, HMGB1, and galanin-like peptide for gestational diabetes mellitus in women with polycystic ovary syndrome.Front Endocrinol (Lausanne). 2025 May 19;16:1602622. doi: 10.3389/fendo.2025.1602622. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40458174 Free PMC article.
References
-
- Stein IF, Leventhal NL. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gyneacol. 1935;29:181–91.
-
- Kistner RW. Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Surv. 1965;20(6):873–900. - PubMed
-
- Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11(11):CD003053. 10.1002/14651858.CD003053.pub6. - PMC - PubMed
-
- Collée J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021;37(10):869–74. 10.1080/09513590.2021.1958310. - PubMed
-
- Legro R, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356(6). 10.1056/NEJMoa063971 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical